MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
|Podcasts|February 12, 2018
Shaking Up the Business of Healthcare: Dr Patricia Salber Interviews Dr Rita Numerof
The United States healthcare system is about to undergo some changes. The proposed cross-sector merger between CVS Health and Aetna created some waves and it was followed by an even bigger surprise: the partnership between Amazon, JP Morgan Chase, and Berkshire Hathaway to create a new healthcare company.
Advertisement
The United States healthcare system is about to undergo some changes. The proposed cross-sector merger between CVS Health and Aetna created some waves and it was followed by an even bigger surprise: the partnership between Amazon, JP Morgan Chase, and Berkshire Hathaway to create a new healthcare company.
Rita Numerof, PhD, the co-founder and president of Numerof & Associates, and Patricia Salber, MD, MBA, of The Doctor Weighs In, discuss the changes and the underlying factors that have led to so many attempts to shake up healthcare.
Listen above or through one of these podcast services:
iTunes:
TuneIn:
Stitcher:
Advertisement
Related to this article
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
This week in health equity and access: PMOS diagnosis, HIV lung cancer screening, transplant access, atopic dermatitis care, and value-based oncology.
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
3
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
4
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
5